Publications by authors named "Mary Solseth"

Claim this Profile
P
Phase I trial of adjuvant mature autologous dendritic cell/allogeneic tumor lysate vaccines in combination with temozolomide in newly diagnosed glioblastoma.
Ian F Parney, S Keith Anderson, Michael P Gustafson, Susan Steinmetz, Timothy E Peterson, Mary Solseth

Neurooncol Adv· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
IMPROvE-CED Trial: Intracoronary Autologous CD34+ Cell Therapy for Treatment of Coronary Endothelial Dysfunction in Patients With Angina and Nonobstructive Coronary Arteries.
Michel T Corban, Takumi Toya, Diana Albers, Faten Sebaali, Bradley R Lewis, Mary L Solseth

Circ Res· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Th17-inducing autologous dendritic cell vaccination promotes antigen-specific cellular and humoral immunity in ovarian cancer patients.
Matthew S Block, Allan B Dietz, Michael P Gustafson, Kimberly R Kalli, Courtney L Erskine, Mary L Solseth

Nat Commun· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Novel strategy for manufacturing autologous dendritic cell/allogeneic tumor lysate vaccines for glioblastoma.
Ian F Parney, Michael P Gustafson, Mary Solseth, Peggy Bulur, Timothy E Peterson

Neurooncol Adv· August 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis